Features new ForeSitetrade; clinical trial methodology designed to reliably predict site successLONDON, June 19, 2017 – As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, is launching its Connected Journeytrade; of data-driven services.

This newly integrated network, powered by PAREXELreg; Analytics capabilities, combines PAREXEL’s technology, processes, and expertise to deliver critical intelligence…

Source: RealWire

Leave a Reply